Average Co-Inventor Count = 4.12
ph-index = 15
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merck Sharp + Dohme Corp. (47 from 2,405 patents)
2. Janssen Pharmaceutica Nv (10 from 2,076 patents)
3. Chiesi Farmaceutici S.p.a. (4 from 328 patents)
4. Merck + Co., Inc. (3 from 4,770 patents)
5. Merck Sharpe & Dohme Corp. (3 from 35 patents)
6. Other (1 from 832,680 patents)
7. Genentech, Inc. (1 from 3,221 patents)
8. F. Hoffmann-la Roche Ag (1 from 168 patents)
9. Zafgen, Inc. (1 from 48 patents)
10. Merch Sharp & Dohme Ltd (1 from 4 patents)
11. Dohme Ltd. (1 from 1 patent)
12. Merck Sharp (1 from 1 patent)
73 patents:
1. 11236084 - Substituted azaindoline derivatives as NIK inhibitors
2. 11186589 - Cyanoindoline derivatives as NIK inhibitors
3. 11180487 - Substituted cyanoindoline derivatives as NIK inhibitors
4. 11136311 - Heteroaromatic derivatives as NIK inhibitors
5. 11001569 - 6-membered heteroaromatic substituted cyanoindoline derivatives as NIK inhibitors
6. 10005776 - Compounds as NIK inhibitors
7. 10005773 - [object Object]
8. 9981962 - Pyrazole derivatives as NIK inhibitors
9. 9981963 - [object Object]
10. 9643964 - 3-(2-aminopyrimidin-4-yl)-5-(3-hydroxypropynyl)-1H-pyrrolo[2,3-C]pyridine derivatives as NIK inhibitors for the treatment of cancer
11. 9156844 - Pyrimidine derivatives and their use in the treatment of respiratory diseases such a COPD
12. 9120802 - Pyrimidine derivatives and their use in the treatment of respiratory diseases such as COPD
13. 9067905 - Sulphone compounds and methods of making and using same
14. 9023855 - Compounds
15. 8691826 - Compounds